Total Payments
$7,272
2024 Payments
$1,166
Companies
43
Transactions
215
Medicare Patients
4,923
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$6,968 (95.8%)
Other$209.30 (2.9%)
Education$94.24 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,968 | 205 | 95.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209.30 | 2 | 2.9% |
| Education | $94.24 | 8 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,939 | 34 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $939.12 | 19 | $0 (2019) |
| Indivior Inc. | $552.21 | 12 | $0 (2020) |
| Daiichi Sankyo Inc. | $408.84 | 6 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $382.80 | 26 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $252.37 | 4 | $0 (2022) |
| Amgen Inc. | $245.77 | 7 | $0 (2022) |
| Orexo US, Inc. | $229.58 | 10 | $0 (2019) |
| Horizon Therapeutics plc | $204.90 | 12 | $0 (2020) |
| PFIZER INC. | $202.84 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,166 | 21 | Abbott Laboratories ($1,011) |
| 2023 | $1,033 | 19 | Abbott Laboratories ($708.52) |
| 2022 | $373.55 | 12 | Teva Pharmaceuticals USA, Inc. ($114.76) |
| 2021 | $345.64 | 13 | Amgen Inc. ($142.65) |
| 2020 | $243.46 | 9 | Indivior Inc. ($122.08) |
| 2019 | $842.51 | 34 | Horizon Therapeutics plc ($154.37) |
| 2018 | $1,738 | 55 | BioDelivery Sciences International, Inc. ($499.90) |
| 2017 | $1,529 | 52 | BioDelivery Sciences International, Inc. ($306.42) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $114.16 | General |
| Category: Neuromodulation | ||||||
| 11/01/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $98.66 | General |
| Category: Neuromodulation | ||||||
| 11/01/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $67.14 | General |
| Category: Neuromodulation | ||||||
| 11/01/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $64.34 | General |
| Category: Neuromodulation | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $38.47 | General |
| Category: Neuromodulation | ||||||
| 09/05/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Neuromodulation | ||||||
| 08/13/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $84.10 | General |
| Category: Neuromodulation | ||||||
| 08/13/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $61.11 | General |
| Category: Neuromodulation | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology | ||||||
| 06/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: PAIN | ||||||
| 06/10/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $136.40 | General |
| Category: Neuromodulation | ||||||
| 05/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: PAIN | ||||||
| 05/08/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $92.14 | General |
| Category: Neuromodulation | ||||||
| 05/08/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $55.99 | General |
| Category: Neuromodulation | ||||||
| 05/08/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Neuromodulation | ||||||
| 04/10/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $45.84 | General |
| Category: Neuromodulation | ||||||
| 04/09/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $117.17 | General |
| Category: Neuromodulation | ||||||
| 03/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: PAIN | ||||||
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PAIN | ||||||
| 11/10/2023 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/28/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $134.55 | General |
| Category: Pain management | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Gastroenterology | ||||||
| 09/29/2023 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,070 | 2,652 | $1.5M | $326,634 |
| 2022 | 8 | 1,063 | 2,412 | $1.4M | $309,207 |
| 2021 | 7 | 1,222 | 2,667 | $1.4M | $321,470 |
| 2020 | 10 | 1,568 | 3,229 | $1.5M | $351,703 |
Total Patients
4,923
Total Services
10,960
Medicare Billing
$1.3M
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 286 | 871 | $653,250 | $207,069 | 31.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 295 | 911 | $546,600 | $54,645 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 553 | $209,974 | $45,534 | 21.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 37 | 40 | $24,000 | $7,791 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $28,430 | $6,862 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 46 | $12,289 | $2,854 | 23.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 77 | 119 | $7,140 | $1,692 | 23.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 46 | 54 | $918.00 | $186.41 | 20.3% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 288 | 746 | $559,500 | $175,835 | 31.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 296 | 834 | $500,400 | $50,778 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 546 | $207,207 | $47,775 | 23.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 72 | 102 | $61,500 | $20,132 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $43,625 | $10,465 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 58 | $15,495 | $3,849 | 24.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 19 | 21 | $1,260 | $316.45 | 25.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 15 | 16 | $272.00 | $57.47 | 21.1% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 270 | 614 | $460,500 | $150,000 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 324 | 864 | $280,800 | $78,835 | 28.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 310 | 779 | $467,400 | $47,606 | 10.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 102 | 168 | $100,800 | $32,671 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 92 | $44,620 | $10,961 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 22 | $4,840 | $943.76 | 19.5% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 103 | 128 | $2,176 | $453.80 | 20.9% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 351 | 786 | $614,956 | $190,847 | 31.0% |
| 80307 | Testing for presence of drug | Office | 2020 | 372 | 892 | $535,200 | $54,389 | 10.2% |
About Dr. Andre Chen, MD
Dr. Andre Chen, MD is a Family Medicine healthcare provider based in Round Rock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902871221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andre Chen, MD has received a total of $7,272 in payments from pharmaceutical and medical device companies, with $1,166 received in 2024. These payments were reported across 215 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,968).
As a Medicare-enrolled provider, Chen has provided services to 4,923 Medicare beneficiaries, totaling 10,960 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Addiction Medicine
- Location Round Rock, TX
- Active Since 02/21/2006
- Last Updated 01/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902871221
Products in Payments
- OCTRODE (Device) $1,571
- BELBUCA (Drug) $784.42
- Movantik (Drug) $398.67
- SUBLOCADE (Drug) $313.66
- SUBOXONE SUBLINGUAL FILM (Drug) $238.55
- Zubsolv (Drug) $229.58
- Xtampza ER (Drug) $225.70
- Aimovig (Biological) $189.25
- SPRINT PNS System (Device) $182.55
- Lucemyra/Lofexidine (Drug) $181.64
- BUNAVAIL 2.1 mg 30-count box (Drug) $150.42
- PROCLAIM (Device) $148.66
- NURTEC ODT (Drug) $147.35
- RELISTOR (Drug) $146.27
- SPRIX (Drug) $134.57
- Horizant (Drug) $125.94
- AJOVY (Drug) $123.20
- Kloxxado (Drug) $117.16
- AUSTEDO (Drug) $114.76
- RAYOS (Drug) $111.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Round Rock
Dr. Steven Daniel, D.o, D.O
Family Medicine — Payments: $25,660
Family Medicine $25,660
Dr. Flint Deshazo, M.d, M.D
Family Medicine — Payments: $22,616
Family Medicine $22,616
Dr. James Boyd, M.d, M.D
Family Medicine — Payments: $22,162
Family Medicine $22,162
Dr. Christopher Putney, M.d, M.D
Family Medicine — Payments: $21,686
Family Medicine $21,686
Mauricio Pinto, M.d, M.D
Family Medicine — Payments: $14,033
Family Medicine $14,033
Mitchell Wong, Md, MD
Family Medicine — Payments: $11,039
Family Medicine $11,039